![](https://www.aptitudehealth.com/wp-content/uploads/2021/08/Report-Mobile-Lymphoma-1.jpg)
CONGRESS COVERAGE: ASH 2020 – FOCUS ON NHL/CLL
Recent developments, and future directions in the management of patients with diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), mantle cell lymphoma (MCL), T-cell lymphoma (TCL), and chronic lymphocytic leukemia (CLL)
![](https://www.aptitudehealth.com/wp-content/uploads/2020/08/Brad-Kahl-MD-Aptitude-Health-Lymphoma.png)
FACULTY CHAIR
Brad S. Kahl, MD
Washington University School of Medicine
TOPICS INCLUDE:
- Advances in Early DLBCL
- Advances in Relapsed/Refractory DLBCL
- Advances in CAR T
- Advances in MCL, FL, MZL
- Advances in T-Cell Lymphoma and Others
- Advances in CLL